Response and resistance in 300 patients with BCR-ABL-positive leukemias treated with imatinib in a single center-Reference-Cited by-同舟云学术

Response and resistance in 300 patients with BCR-ABL-positive leukemias treated with imatinib in a single center

Published:2005-03-03 Issue:8 Volume:103 Page:1659-1669
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Lahaye Tanja,Riehm Birte,Berger Ute,Paschka Peter,Müller Martin C.,Kreil Sebastian,Merx Kirsten,Schwindel Uwe,Schoch Claudia,Hehlmann Rüdiger,Hochhaus Andreas

Funder

Novartis Pharma, Nürnberg, Germany

German Bundesministerium für Bildung und Forschung

European LeukemiaNet

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference37 articles.

1. Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia;Kantarjian;N Engl J Med.,2002

2. Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study;Talpaz;Blood.,2002

3. Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study;Sawyers;Blood.,2002

4. A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoid leukemias;Ottmann;Blood.,2002

5. Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy;Hochhaus;Leukemia.,2002

Cited by 207 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling the Mechanisms of Sensitivity to Anti-FGF Therapies in Imatinib-Resistant Gastrointestinal Stromal Tumors (GIST) Lacking Secondary KIT Mutations;Cancers;2023-11-09

2. Approved Small-Molecule ATP-Competitive Kinases Drugs Containing Indole/Azaindole/Oxindole Scaffolds: R&D and Binding Patterns Profiling;Molecules;2023-01-17

3. Clinical Application of Biomarkers for Hematologic Malignancies;Biomarkers in Medicine;2022-08-30

4. Chronic Myeloid Leukemia: Part I—Real-World Treatment Patterns, Healthcare Resource Utilization, and Associated Costs in Later Lines of Therapy in the United States;Journal of Health Economics and Outcomes Research;2022-08-04

5. Chronic Myeloid Leukemia: Part I—Real-World Treatment Patterns, Healthcare Resource Utilization, and Associated Costs in Later Lines of Therapy in the United States;Journal of Health Economics and Outcomes Research;2022-08-04